Decabromodiphenyl ether causes insulin resistance and glucose and lipid metabolism disorders in mice

Table 3 Comparisons of blood lipid indexes in mice of each group (mmoL/L)

Group	TC	TG	LDL-C	HDL-C
High dose	5.29 ± 1.20a,b,c	1.46 ± 0.36a,b,c	2.44 ± 0.21a,b,c	1.33 ± 0.12a,b,c
Medium-high dose	4.64 ± 0.49a	1.12 ± 0.11a	2.14 ± 0.29a,c	1.51 ± 0.12a,c
Medium dose	3.67 ± 0.49a	0.97 ± 0.14a	1.95 ± 0.49a,c	1.53 ± 0.17a
Medium-low dose	3.48 ± 0.64a	0.92 ± 0.18a	1.78 ± 0.34a	1.72 ± 0.10a
Low dose	3.36 ± 1.11a	0.91 ± 0.06a	1.70 ± 0.15a	1.73 ± 0.10a
Control	2.95 ± 1.35	0.75 ± 0.07	1.27 ± 0.15	1.95 ± 0.10
F value	5.38	10.32	13.3	17.44
P value	0.002	0.001	0.001	0.001

TC: Total cholesterol; TG: Tri-glyceride; LDL-C: Low-density lipoprotein cholesterol; HDL-C: High density lipoprotein cholesterol.

^aP < 0.05 compared with the control group.

^bP < 0.05 compared with the medium dose group.

^cP < 0.05 compared with the low dose group.